428
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

, , , , , , , , , , , & show all
Pages 2264-2267 | Received 28 Sep 2016, Accepted 18 Jan 2017, Published online: 13 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephan R. Bohl, Lars Bullinger & Frank G. Rücker. (2018) Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia. Expert Review of Hematology 11:5, pages 361-371.
Read now

Articles from other publishers (2)

Zizhen Chen, Junzhe Song, Wenjun Wang, Jiaojiao Bai, Yuhui Zhang, Jun Shi, Jie Bai & Yuan Zhou. (2021) A novel 4‐mRNA signature predicts the overall survival in acute myeloid leukemia . American Journal of Hematology 96:11, pages 1385-1395.
Crossref
Ferda Ari, Rudolf Napieralski, Oguzhan Akgun, Viktor Magdolen & Engin Ulukaya. (2021) Epigenetic modulators combination with chemotherapy in breast cancer cells. Cell Biochemistry and Function 39:4, pages 571-583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.